4//SEC Filing
Shaw Kevin G. 4
Accession 0000905148-25-000337
CIK 0001661059other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:23 PM ET
Size
5.1 KB
Accession
0000905148-25-000337
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Shaw Kevin G.
Sr VP, General Counsel
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-01-31+66,125→ 66,125 totalExercise: $0.80Exp: 2035-01-30→ Common Stock (66,125 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on January 31, 2026. The remainder vests in 36 monthly installments beginning on February 28, 2026.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
Related Parties
1- filerCIK 0001953666
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:23 PM ET
- Size
- 5.1 KB